home ›› patient information ›› media releases ›› TBRRI receives CCO research award
TBRRI Receives Inaugural CCO Research Chair Award

Thursday, June 19, 2008


TBRRI Research Award

Dr. John Rowlands, TBRRI Founding Scientific Director and Dr. Joseph Pater, Vice President, Clinical and Translational Research for Cancer Care


Click to listen to this page using ReadPlease Less than one hour before its first Annual General Meeting, the Thunder Bay Regional Research Institute celebrated yet another success with the presentation of a $500,000 Cancer Care Ontario Research Chair Award.

 

Dr. Joseph Pater, Vice President, Clinical and Translational Research for Cancer Care Ontario (CCO), officially unveiled the new CCO Research Chairs program and announced the Thunder Bay Regional Research Institute as one of seven award recipients in Ontario. The program, funded by the Ministry of Health and Long-Term Care, is designed to engage new scientists in cancer research in Ontario and to support outstanding scientists already working in the field.

 

TBRRI Research Award

“Research plays an important role in preventing the onset of cancer and improving services for those who develop the disease,” Dr. Pater said. “The Thunder Bay Regional Research Institute is an asset for the entire cancer system, and CCO is pleased to support it with a CCO Research Chair as it continues to grow and develop.”

 

Dr. John Rowlands, Founding Scientific Director for the Thunder Bay Regional Research Institute, accepted the award on behalf of the Institute. He said it will be used to aid in recruitment for the Molecular Imaging and Advanced Diagnostics Research Program of the Research Institute (formerly known as the MMRC).

 

TBRRI Research Award

“With molecular imaging and advanced diagnostics as the overall focus, the program will be organized around three core themes: Advanced Detection Devices, Biomarker Discovery, and Imaging Guided Interventions. The CCO Research Chair will be used to recruit a Radiation Oncology Clinician Scientist who will work in the clinical aspects of the Research Institute,” Dr. Rowlands said.

 

Mr. Keith Jobbitt, Chair of the Board of Directors for the Thunder Bay Regional Research Institute, said the CCO Research Chair announcement reflects both the Research Institute’s success over the past year and the future directions mapped out in the Institute’s first Strategic Plan, which was also revealed today.

 

TBRRI Research Award

“The Thunder Bay Regional Research Institute has a clear vision: we will transform patient care at Thunder Bay Regional Health Sciences Centre and beyond through patient-centred research. This means all research done at the Research Institute will be motivated by patient needs, which is quite a unique mandate in the scientific arena,” Mr. Jobbitt said.

 

TBRRI Research Award

“The CCO Research Chair Announcement further demonstrates confidence in our Strategic Plan and in our Research Institute team. Partnerships like the one established with CCO, coupled with the outstanding recruitment efforts of Dr. Rowlands and Dr. Mark Poznansky, Chief Research Officer, will ensure our success in achieving our goals over the next five years,” said Mr. Michael Power, CEO of the Thunder Bay Regional Research Institute and Vice President of Regional Cancer and Diagnostic Services, Thunder Bay Regional Health Sciences Centre.

 

 

Thunder Bay Regional Research Institute Backgrounder

Cancer Care Ontario Research Chairs Program Media Release

 

 

:: back to Media Releases ::